ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy

Rocio Garcia-Carbonero,Anja Rinke,Juan W. Valle,Nicola Fazio,Martyn Caplin,Vera Gorbounova,Juan O'Connor,Barbro Eriksson,Halfdan Sorbye,Matthew H. Kulke,Jie Chen,Jenny Falkerby,Frederico Costa,Wouter W. de Herder,Catherine Lombard-Bohas,Marianne Pavel

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy

2017

Rocio Garcia-Carbonero
Anja Rinke
Juan W. Valle
Nicola Fazio
Martyn Caplin
Vera Gorbounova
Juan O'Connor
Barbro Eriksson
Halfdan Sorbye
Matthew H. Kulke
Jie Chen
Jenny Falkerby
Frederico Costa
Wouter W. de Herder
Catherine Lombard-Bohas
Marianne Pavel

Systemic chemotherapy is indicated in progressive or bulky advanced pancreatic neuroendocrine tumors (NETs) and in grade 3 (G3) neuroendocrine neoplasms (NENs) as per ENETS guidelines. Chemotherapy ma

Keywords:

Diabetes mellitus
Neuroendocrine tumors
Systemic therapy
Oncology
Neurology
Chemotherapy
Medicine
Internal medicine
Irinotecan
Adverse effect
Rectum
Progressive disease
Dacarbazine
Etoposide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations